| Title | Author(s) | Year | View Count |  | Overexpression of eIF5A-2 is an adverse prognostic marker of survival in stage I non-small cell lung cancer patients | He, LR; Zhao, HY; Li, BK; Liu, YH; Liu, MZ; Guan, XY; Bian, XW; Zeng, YX; Xie, D | 2011 | 166 |
| High expression of EZH2 is associated with tumor aggressiveness and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy | He, LR; Liu, MZ; Li, BK; Jia, WH; Zhang, Y; Liao, YJ; Chen, YC; Zhang, LJ; Guan, XY; Zeng, YX; Kung, HF; Xie, D | 2010 | 468 |
| Overexpression of AIB1 negatively affects survival of surgically resected non-small-cell lung cancer patients | He, LR; Zhao, HY; Li, BK; Zhang, LJ; Liu, MZ; Kung, HF; Guan, XY; Bian, XW; Zeng, YX; Xie, D | 2010 | 570 |
 | Prognostic impact of H3K27me3 expression on locoregional progression after chemoradiotherapy in esophageal squamous cell carcinoma | He, LR; Liu, MZ; Li, BK; Rao, HL; Liao, YJ; Guan, XY; Zeng, YX; Xie, D | 2009 | 192 |
| Clusterin as a predictor for chemoradiotherapy sensitivity and patient survival in esophageal squamous cell carcinoma | He, LR; Liu, MZ; Li, BK; Rao, HL; Liao, YJ; Zhang, LJ; Guan, XY; Zeng, YX; Xie, D | 2009 | 168 |
| Overexpression of AIB1 predicts resistance to chemoradiotherapy and poor prognosis in patients with primary esophageal squamous cell carcinoma. | He, LR; Liu, MZ; Li, BK; Rao, HL; Deng, HX; Guan, XY; Zeng, YX; Xie, D | 2009 | 151 |
| Overexpression of AIB1 in nasopharyngeal carcinomas correlates closely with advanced tumor stage | Liu, MZ; Xie, D; Mai, SJ; Tong, ZT; Shao, JY; Fu, YS; Xia, WJ; Kung, HF; Guan, XY; Zeng, YX | 2008 | 72 |
| Protein expression and amplification of AIB1 in human urothelial carcinoma of the bladder and overexpression of AIB1 is a new independent prognostic marker of patient survival | Luo, JH; Xie, D; Liu, MZ; Chen, W; Liu, YD; Wu, GQ; Kung, HF; Zeng, YX; Guan, XY | 2008 | 71 |
|
